Vasoactive intestinal polypeptide facilitates the late component of the 5-hydroxytryptamine-induced discharge in the cat superior cervical ganglion

Neurosci Lett. 1987 Jan 2;73(1):59-64. doi: 10.1016/0304-3940(87)90031-0.

Abstract

The intra-arterial administration of vasoactive intestinal polypeptide (VIP, 1-10 micrograms, i.a.) to the cat superior cervical ganglion facilitated or unmasked the late component but not the early component of the 5-hydroxytryptamine (5-HT, 0.5-50 micrograms, i.a.)-induced postganglionic discharge. The facilitation occurred in acutely and chronically decentralized ganglia. The early and late 5-HT discharges were blocked by MDL-72222, a 5-HT antagonist, but not by cholinergic antagonists. These data together with previous observations indicate that VIP selectively facilitates slow cholinergic and non-cholinergic excitatory mechanisms in autonomic ganglia.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Atropine / pharmacology
  • Autonomic Fibers, Postganglionic / drug effects
  • Autonomic Fibers, Postganglionic / physiology*
  • Cats
  • Female
  • Ganglia, Sympathetic / drug effects
  • Ganglia, Sympathetic / physiology*
  • Hexamethonium
  • Hexamethonium Compounds / pharmacology
  • Male
  • Membrane Potentials / drug effects
  • Serotonin / physiology*
  • Serotonin Antagonists / pharmacology
  • Tropanes / pharmacology
  • Vasoactive Intestinal Peptide / physiology*

Substances

  • Hexamethonium Compounds
  • Serotonin Antagonists
  • Tropanes
  • Serotonin
  • Vasoactive Intestinal Peptide
  • Hexamethonium
  • Atropine
  • bemesetron